VRCA - ヴェリカ・ファ―マシュ―ティカルズ (Verrica Pharmaceuticals Inc.)

VRCAのニュース

   VRCA Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Verrica Pharmaceuticals Inc. and Lead Plaintiff Deadline: September 14, 2020  2020/09/14 15:00:00 PR Newswire
NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ: VRCA) and certain of its officers, on behalf of…
   DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2020/09/11 14:55:08 NewMediaWire
Los Angeles, CA - (NewMediaWire) - September 11, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (NASDAQ: VRCA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between September 16, 2019 and June 29, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before September 14, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.
   Insider Weekends: Chuck Davis Purchases $60 Million Worth Of AXIS Capital  2020/08/23 22:05:32 Seeking Alpha
Insider buying decreased last week. Notable Insider Buys: AXIS Capital Holdings Limited, Red Rock Resorts, Inc., Kinder Morgan, Inc., Live Oak Bancshares, Inc., Verrica Pharmaceuticals Inc.
   Insider Buys Verrica Pharmaceuticals Stock  2020/08/18 11:45:00 Benzinga
Shares of Verrica Pharmaceuticals Inc (NASDAQ:VRCA) moved higher by 14.7% from the previous closing price. A Form 4 filing filed with the SEC on Tuesday, …
   The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings  2020/08/05 11:35:15 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD ) (FDA approved the emergency use of Abiomed's Impella heart pump in combination with an oxygen machine to treat Covid-19 patients who suffer heart and lung failure) Allovir Inc (NASDAQ: ALVR ) (IPOed Thursday) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced positive preclinical data for its lead drug in Multiple System Atrophy) ALX Oncology Holdings Inc (NASDAQ: ALXO ) Cardiff Oncology Inc (NASDAQ: CRDF ) Cocrystal Pharma Inc (NASDAQ: COCP ) (announced the publication of positive preclinical animal studies of coronavirus antiviral compounds in a medical journal) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fulgent Genetics Inc (NASDAQ: FLGT ) Hologic, Inc. (NASDAQ: HOLX ) Inari Medical Inc (NASDAQ: NARI ) Inozyme Pharma Inc (NASDAQ: INZY ) Quidel Corporation (NASDAQ: QDEL ) Renalytix AI PLC (NASDAQ: RNLX ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) Twist Bioscience Corp (NASDAQ: TWST ) Varian Medical Systems, Inc. (NYSE: VAR ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 4) Pandion Therapeutics Holdco LLC (NASDAQ: PAND ) Verrica Pharmaceuticals Inc (NASDAQ: VRCA ) Stocks In Focus Novavax Announces Positive Phase 1 Data For Coronavirus Vaccine Novavax, Inc. (NASDAQ: NVAX ) announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID 19 vaccine NVX CoV2373 with and without Matrix M adjuvant, which showed the investigational vaccine was generally well-tolerated and elicited robust antibody responses numerically superior to that seen in human convalescent sera.
   VRCA Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Verrica Pharmaceuticals Inc. and Lead Plaintiff Deadline: September 14, 2020  2020/09/14 15:00:00 PR Newswire
NEW YORK, Sept. 14, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ: VRCA) and certain of its officers, on behalf of…
   DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm  2020/09/11 14:55:08 NewMediaWire
Los Angeles, CA - (NewMediaWire) - September 11, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (NASDAQ: VRCA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between September 16, 2019 and June 29, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before September 14, 2020. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.
   Insider Weekends: Chuck Davis Purchases $60 Million Worth Of AXIS Capital  2020/08/23 22:05:32 Seeking Alpha
Insider buying decreased last week. Notable Insider Buys: AXIS Capital Holdings Limited, Red Rock Resorts, Inc., Kinder Morgan, Inc., Live Oak Bancshares, Inc., Verrica Pharmaceuticals Inc.
   Insider Buys Verrica Pharmaceuticals Stock  2020/08/18 11:45:00 Benzinga
Shares of Verrica Pharmaceuticals Inc (NASDAQ:VRCA) moved higher by 14.7% from the previous closing price. A Form 4 filing filed with the SEC on Tuesday, …
   The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings  2020/08/05 11:35:15 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD ) (FDA approved the emergency use of Abiomed's Impella heart pump in combination with an oxygen machine to treat Covid-19 patients who suffer heart and lung failure) Allovir Inc (NASDAQ: ALVR ) (IPOed Thursday) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced positive preclinical data for its lead drug in Multiple System Atrophy) ALX Oncology Holdings Inc (NASDAQ: ALXO ) Cardiff Oncology Inc (NASDAQ: CRDF ) Cocrystal Pharma Inc (NASDAQ: COCP ) (announced the publication of positive preclinical animal studies of coronavirus antiviral compounds in a medical journal) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fulgent Genetics Inc (NASDAQ: FLGT ) Hologic, Inc. (NASDAQ: HOLX ) Inari Medical Inc (NASDAQ: NARI ) Inozyme Pharma Inc (NASDAQ: INZY ) Quidel Corporation (NASDAQ: QDEL ) Renalytix AI PLC (NASDAQ: RNLX ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) Twist Bioscience Corp (NASDAQ: TWST ) Varian Medical Systems, Inc. (NYSE: VAR ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 4) Pandion Therapeutics Holdco LLC (NASDAQ: PAND ) Verrica Pharmaceuticals Inc (NASDAQ: VRCA ) Stocks In Focus Novavax Announces Positive Phase 1 Data For Coronavirus Vaccine Novavax, Inc. (NASDAQ: NVAX ) announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID 19 vaccine NVX CoV2373 with and without Matrix M adjuvant, which showed the investigational vaccine was generally well-tolerated and elicited robust antibody responses numerically superior to that seen in human convalescent sera.
   Shareholder Alert: Robbins LLP Announces Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading Shareholders  2020/07/16 17:58:00 Business Wire
SAN DIEGO & WEST CHESTER, Pa.--(BUSINESS WIRE)---- $VRCA #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between September 16, 2019 and June 29, 2020. Verrica is a clinical stage medical dermatology company that develops and commercializes dermatological treatments. VP-102 is the Company's lead product candidate for the treatme
   The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)  2020/07/14 21:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $VRCA #classaction--The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Eastern District of Pennsylvania captioned Potter v. Verrica Pharmaceuticals Inc., et al., (Case No. 20-cv-03447) on behalf of persons and entities that purchased or otherwise acquired Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) securities between September 16, 2019 and June 29, 2020, inclusive (the “Class Peri
   VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.  2020/07/14 18:08:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $VRCA #classaction--VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.
   The Law Offices of Frank R. Cruz Continues Its Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors  2020/07/09 14:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $VRCA #classaction--The Law Offices of Frank R. Cruz continues its investigation on behalf of Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On June 29, 2020, Verrica disclosed receipt of a letter from the U.S. Food and Drug Administration ("FDA") regarding the Company's New Drug Applicatio
   Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors  2020/07/08 18:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $VRCA #classaction--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. on Behalf of Investors

calendar